Has Vipul Shah, MD received payments from drug or device companies?

Yes. Drug and device makers reported $487,514 in general payments to Vipul Shah, MD across 874 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Vipul Shah, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Vipul Shah, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Vipul Shah, MD

Cardiovascular Disease · Lancaster, SCNPI 1841246584

Payments from drug & device makers

$487,514in general payments, 2019–2025

Across 874 payments — averaging $557.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

American Regent$160K
Bayer$109K
Biotronik Inc.$68K
Astrazeneca UK Limited$49K
Boehringer Ingelheim Pharma GmbH & Co.kg$29K
Vifor (international) Ltd.$19K
plus $54K from 39 others

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
American Regent	14	$159,969
Bayer	78	$108,742
Biotronik Inc.	440	$67,570
Astrazeneca UK Limited	3	$48,976
Boehringer Ingelheim Pharma GmbH & Co.kg	2	$29,277
Vifor (international) Ltd.	17	$18,850
Boehringer Ingelheim International GmbH	5	$17,960
CSL Behring	11	$16,600
Novartis	42	$14,597
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	30	$784
Pfizer	37	$545
Esperion Therapeutics, Inc.	24	$478
Sanofi-aventis U.S. LLC	24	$461
Merck	25	$402
Astellas Pharma US Inc	7	$354
E.r. Squibb & Sons, L.L.C.	19	$310
AstraZeneca	17	$268
Amarin Pharma, Inc.	13	$193
Amgen	11	$175
Johnson & Johnson	9	$133
Boehringer Ingelheim	5	$112
Edwards Lifesciences	6	$94
Kiniksa Pharmaceuticals International, PLC	3	$76
Inspire Medical Systems, Inc.	3	$52
Arbor Pharmaceuticals, Inc.	3	$45
Kiniksa Pharmaceuticals, Ltd.	2	$42
GSK	2	$39
Corvista Health, Inc.	2	$36
Actelion Pharmaceuticals US, Inc.	2	$34
Vifor Pharma, Inc.	2	$34
Itamar Medical Inc	1	$32
Xeris Pharmaceuticals, Inc.	1	$26
Boston Scientific	1	$25
Mannkind Corporation	1	$25
Regeneron Healthcare Solutions, Inc.	2	$24
Lundbeck LLC	1	$22
Arineta, Inc	1	$21
Kowa Pharmaceuticals America, Inc.	1	$21
Philips North America LLC	1	$18
Cvrx, Inc.	1	$18
Lexicon Pharmaceuticals, Inc.	1	$15
Scpharmaceuticals Inc.	1	$15
Abbott	1	$14
Gilead	1	$14
G Medical Diagnostic Services, Inc.	1	$12

How this compares

$487,514 in reported general payments places this provider in the 95th percentile of 257 cardiovascular disease providers in South Carolina.

See all cardiovascular disease providers in South Carolina →

Medicare billing

Part B allowed, 2024

$782,644

Medicare patients

1,491

Services billed

8,991

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other cardiovascular disease in Lancaster

Deepak ShahLancaster$48K
Mark CiminelliLancaster$37K
Brent McLaurinAnderson$1.1M
Robert BiedermanCharleston$801K
James MerriamGreenville$728K
Arthur EberlyGreenville$438K
Gregory SanGreenville$429K
Naresh MoriRock Hill$408K
Priya KumarGreenwood$351K
Dev VazGreenville$257K

See the full list for South Carolina →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →